@EChabriere
Ravi d'apprendre que l'IHU est utilisateur de PubPeer. On attire votre attention sur le règlement
Notamment les règles concernant :
- les insultes
- la diffamation
- la nouveauté
- le minimum d'appui
et éventuellement
- les théories complotistes
La France est une grande nation scientifique: parmi les 10 publications scientifiques les plus citées au monde pendant cette crise, 2 étaient françaises. Grâce à
#FranceRelance
et à la
#LoiRecherche
, nous permettons un réinvestissement massif dans la recherche.
#60MinutesBusiness
The online intimidation and legal threats against
@MicrobiomDigest
, who signs her critiques, are examples of why PubPeer offers the protection of anonymity, which is combined with strict content moderation.
We now have a
@zotero
extension that indicates which articles in your Zotero library have PubPeer comments. You can find it here.
We're interested in any feedback!
Reminder: PubPeer comments have to be supported with publicly verifiable information:
e.g. One cannot write a comment claiming that authors are conflicted without documenting a conflict of interest with publicly verifiable facts.
PubPeer recently turned ten years old, and in our first ten years our amazing users left 130k comments on ~45k publications across >4k journals. These numbers are impressive and we'd like to build on them and encourage different types of comments. So today we are announcing:
Are you a researcher believing that academic whistleblower's work (e.g.,
@MicrobiomDigest
) is instrumental to ethical, trustworthy, and honest research, we invite you to read and sign our Open Letter.
Letter:
Signature collection:
A reminder: accusations of misconduct and insults are forbidden on PubPeer and this is enforced by our
moderation policies. We have no control over what other people write on social media.
That's interesting. Sychronised "organic" criticism of
@MicrobiomDigest
in French. Discussion of the chloroquine study is strategic. We counted at least 8 of these.
Cc
@Le___Doc
"I think that, in two decades, we will look back on the past 60 years — particularly in biomedical science — and marvel at how much time and money has been wasted on flawed research."
@MicrobiomDigest
reviews the journals. With receipts.
At these journals, the last people to hear about any problems in papers are the readers. Install the PubPeer browser and
@zotero
extensions to learn what the journals won't tell you:
Several people asked me what the worst journals are to respond to image duplication or other concerns and/or to retract.
Here are a couple from my list:
(thread)
Starting today, we will begin highlighting comments containing incisive scientific discussion by putting them on the PubPeer front page. We will also reward the best of those comments with prizes of $300.
If you want to guarantee that your anonymous comment won't pass PubPeer moderation, here is a good opening sentence: "This is the most shocking case of clinical research fraud that my colleagues and I have uncovered to date".
In case you needed another reason to use
@zotero
:
"the word processor plugin will also warn you if there [are] any existing citations in your document that have been retracted"
Readers shouldn't have to install a browser plugin to be alerted to discussion of an article.
@biorxivpreprint
links to PubPeer comments. Why don't any of the forward thinking journals?
@mbeisen
?
Until they do there's this:
It's time. Someone should build a website to name authors who won't share data. Linked to doi, authors auto emailed when claim made against one of their papers, space for author to post their rationale, easy way to mark 'resolved!' if data sent, easy way to search.
#opendata
As part of PubPeer's written testimony to the Science Committee of the US House of Representatives, we wish to give examples of influential papers with unresolved integrity or quality issues. Please suggest your best cases.
1/2
Our small team of volunteers has found 400 papers, based on similarities in titles, keywords and layout. These were relatively easy to find, although we did put in many hours of unpaid work to find these papers.
In the 6 years of PubPeer this comment from a few hours ago is one of the most poetic author defenses we've seen so far:
"The world is so large under the electron microscope that if you want, you can find two identical ones."
PubPeer is a platform for factual, scientific discussion. If you believe that comments are abusive, unsupported or otherwise infringe on our guidelines
we encourage you to report them. We examine all reports carefully.
Universities and other scientific institutions can now receive immediate alerts when an article published by a member of their institution receives a comment on PubPeer:
@OdedRechavi
@SupremeHaggis
Our experience from running an anonymous scientific publication commenting platform over the last 8 years is that worries of trolling are overblown and easily avoided with clear guidelines and moderation.
Isn't the point of science to question everything? Do we really want "peer-reviewed" and journal name to signal any sort of quality? How about publish everything (including reviews) and trust nothing?
@mbeisen
You're not alone. 8 years ago when we made the choice to allow anonymous comments we took a LOT of heat. With clear guidelines () and moderation it hasn't become the monster that was predicted and we now see many people softening their opinion on anonymity.
All comments from PubMed Commons can now be consulted on PubPeer and
they will remain on PubMed for anyone with the PubPeer browser plugin:
Thanks to the
@PubMedCommons
team for sharing this valuable resource.
Commenters using PubPeer's strong, user-controlled anonymity to discuss publications and data (factually and scientifically) will reduce their legal exposure.
It seems that Jonathan Pruitt is trying to prevent people talking publicly about the unexpected duplications in his datasets. Luckily, the discussion continues on
@PubPeer
.
We're delighted to report that
@EndNoteNews
users will now be notified of retractions of any publications in their library, thanks to the integration of our database.
Thread: a short update on moderation on PubPeer.
Any success of PubPeer is due entirely to the utility and accuracy of the comments submitted by our users. In order to maintain the highest quality of discussion, we continually refine our moderation policies.
How did Springer Nature get into 3 **billion** euro debt? Is public research covering a shady business deal?
"The entire proceeds would have been used to cut Springer Nature’s net debt by a third. That currently stands at roughly 3 billion euros."
Wishing a Happy New Year to all PubPeer and Peeriodicals contributors! Our sites would quite simply not exist without you. Their utility flows entirely from your expertise and hard - sometimes thankless - work. Thank you all.
A reminder that legal threats are not a theoretical risk when you question the work of others. That's one of the reasons we allow anonymity on PubPeer (while moderating comments). A lot of the historical debate on the issue summarised here:
Peer review does not stop bad science being published.
Peer review does not validate a papers findings.
Peer review does not significantly improve (most) studies that have been preprinted.
Peer review does cost considerable time and money.
@ryneches
@biorxivpreprint
Are you aware that you can start your own journal in a few seconds and send these articles out for review? Even create an editorial board.
@PLOSONE
@MicrobiomDigest
Hi PLoS, if you appreciate these issues being brought to your attention you might consider subscribing to a dashboard so your responses can be more timely:
I am currently posting all of those on
@Pubpeer
. Heck of a job, but at least they are now flagged for everyone who has PubPeer's browser extension.
Some might be just errors, some might be intentional, but all are worth responding to.
These journal editors chose to ignore.
@lakens
We have all
@PubMedCommons
comments and will add them to PubPeer to preserve them as soon as we can. We are currently focused on putting the final touches on another exciting project that we hope to release over the next few months. Stay tuned.
Putting aside personalities, reputations and ad hominems,
@PubPeer
we welcome focused and dispassionate scientific discussion. Authors are very welcome to respond with clarifications to questions about their work.
The witchhunter
@MicrobiomDigest
is not attentive to details when she judges that a study is useful to her paranoiac fights!
Control group was treated with azithromycin.
Nearly dying patients with lymphopenia were treated with hydroxychloroquine.
Fraudulent study. Fake news.
Finally, we remind another "frequent reporter" that PubPeer user pseuodyms are assigned randomly from the tree of life and are therefore not chosen by the commenter.
Dicksonia Gigantea is a tree fern:
We have updated our commenting guideline FAQs to reflect current moderation policies, which have evolved significantly since the site launched in 2012. We particularly draw your attention to the "content" and "quality" questions:
What a shameful state of affairs it is when people DM me privately to say that entire sub-fields in their discipline are horrendously p-hacked but that they can't put their name to such statements publicly for fear of reprisals. Senior academics, hang your heads in shame.
Yet the final versions are costing millions...
"Our analysis revealed that the text contents of the scientific papers generally changed very little from their pre-print to final published versions."
.
@PubPeer
should not be thought as for posting only criticism and concerns - positive comments are welcome as well, and perhaps the conclusions of journal club, concise summary of strengths/weaknesses